WASHINGTON UNIVERSITY
NAPS2 Clinical Core
NAPS2 Clinical Core is a funding opportunity from WASHINGTON UNIVERSITY, up to 755266, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
ABSTRACT: NAPS2 CLINICAL CORE The North American Prodromal Synculeinopathy Consortium for RBD, Stage 2 (NAPS2) protocol represents an expanded and integrated international research consortium focused on RBD involving eight cores and one project. NAPS2 is designed to substantially and comprehensively increase the…